ArticleFrontiers in immunology2022

Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections.

Yukiya Kurahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.